Global Precision Medicine Market 2018-2028 with 2017 as the Base Year – Market to Reach $216.75 Billion

Dublin, Feb. 06, 2019 (GLOBE NEWSWIRE) -- The "Global Precision Medicine Market: Focus on Precision Medicine Ecosystem, Applications, 13 Countries Mapping, and Competitive Landscape - Analysis and Forecast: 2018-2028" report has been added to ResearchAndMarkets.com's offering.

Global Precision Medicine Market to Reach $216.75 Billion by 2028

Currently, the precision medicine market is gaining preference among the masses due to the growth of personal healthcare devices and integration of smart technologies in the healthcare system. In addition, increasing collaborations and partnerships between various ecosystem players are aiding in the robust growth of the precision medicine market.

The growth in the precision medicine market is propelled by an increasing demand for personalized treatment, technological innovation and advancement (including Biomarker-based tests/kits, next gene sequencing, and precise imaging), government support and regulations, which consequently, have created a demand for the precision medicine solutions.

Governmental regulations and standards are sustaining the growth and development of the precision medicine market. The primary aim of these regulations is to make precision medicines more adaptable and focused towards genetic diseases related to oncology, skin, respiratory, central nervous system, cardiovascular, and infectious diseases, among others.

The purpose of this study is to gain a holistic view of the precision medicine market in terms of various influencing factors, such as recent trends, technological advancements, and role of various key stakeholders in the market. The report constitutes an in-depth study of the global precision medicine market, including a thorough analysis of the products across different regions.

The study also presents a detailed analysis of the market trends, and the market size for the period 2017-2028, wherein 2017 is the base year, and the years from 2018 to 2028 constitute the forecast period.

Key questions answered in the report:

  • What are the major market drivers, challenges, and opportunities in the global precision medicine market?
  • What are the underlying structures resulting in the emerging trends within the precision medicine market?
  • What was the market value of the leading segments and sub-segments of the global precision medicine market in 2017?
  • How will each segment of the global precision medicine market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2028?
  • What are the influencing factors that may affect the market share of the key players?
  • How will the industry evolve during the forecast period 2018- 2028?
  • What are the key developmental strategies which are implemented by the key players to sustain in the competitive market?
  • What are the key ecosystem type in the global precision medicine market? What are the major benefits of each type?
  • How has the market been segmented on the basis of application type? Which application type is dominating the global precision medicine market and what is the reason behind such domination?
  • Which ecosystem type is having the most promising growth and in which application type?
  • What is the market share of each of the companies in the global precision medicine market and what are their contributions?
  • What is the scope of each type of ecosystem in North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World?
  • What is the growth potential of precision medicine in each region, including North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World?
  • How many countries are covered in each geographical region? Which country is currently dominating the precision medicine market?

Key Topics Covered:

Executive Summary

1 Market Overview
1.1 Introduction
1.2 Precision Medicine: A Frontier in the Genesis of Patient-centric Medicine
1.3 Precision Medicine: Remodeling the One-Size-Fits-All Theory to Individually Tailored Therapy
1.4 Initiatives and Programs
1.5 Assumptions and Limitations for Market Size Calculations
1.6 Precision Medicine: Enabling Technologies
1.6.1 Innovators
1.6.1.1 3D DNA Printing
1.6.1.1.1 Introduction
1.6.1.1.2 Role of 3D DNA Printing
1.6.1.2 RNA-Seq
1.6.1.2.1 Introduction
1.6.1.2.2 Role of RNA-Seq in Precision Medicine
1.6.1.2.3 Key Players
1.6.1.3 4D Molecular Imaging
1.6.1.3.1 Introduction
1.6.1.3.2 Role of 4D Molecular Imaging in Precision Medicine
1.6.1.3.3 Key Players
1.6.2 Early Adopters
1.6.2.1 CRISPR
1.6.2.1.1 Introduction
1.6.2.1.2 Role of CRISPR in Precision Medicine
1.6.2.1.3 Key Players
1.6.2.2 Blockchain
1.6.2.2.1 Introduction
1.6.2.2.2 Role of Blockchain in Precision Medicine
1.6.2.2.3 Key Players
1.6.2.3 Imaging Informatics
1.6.2.3.1 Introduction
1.6.2.3.2 Role of Imaging Informatics in Precision Medicine
1.6.2.3.3 Key Players
1.6.3 Early Majority
1.6.3.1 Artificial Intelligence (AI)
1.6.3.1.1 Introduction
1.6.3.1.2 Role of Artificial Intelligence in Precision Medicine
1.6.3.1.3 Key Players
1.6.3.2 Circulating free DNA (cfDNA)
1.6.3.2.1 Introduction
1.6.3.2.2 Role of cfDNA in Precision Medicine
1.6.3.2.3 Key Players
1.6.3.3 Big Data
1.6.3.3.1 Introduction
1.6.3.3.2 Role of Big Data in Precision Medicine
1.6.3.3.3 Key Players
1.6.3.4 Next-Generation Sequencing (NGS)
1.6.3.4.1 Introduction
1.6.3.4.2 Role of NGS in Precision Medicine
1.6.3.4.3 Key Players
1.6.3.5 Health Informatics
1.6.3.5.1 Introduction
1.6.3.5.2 Role of Health informatics in Precision Medicine
1.6.3.5.3 Key players
1.6.3.6 Bioinformatics
1.6.3.6.1 Introduction
1.6.3.6.2 Role of Bioinformatics in Precision Medicine
1.6.3.6.3 Key Players
1.6.4 Late Majority
1.6.4.1 Polymerase Chain Reactions (PCR)
1.6.4.1.1 Introduction
1.6.4.1.2 Role of PCR in Precision Medicine
1.6.4.1.3 Key players
1.6.4.2 Microarray
1.6.4.2.1 Role of Microarray in Precision Medicine
1.6.4.2.2 Key Players

2 Market Dynamics
2.1 Impact Analysis
2.2 Market Drivers
2.2.1 Advancement of Sequencing Technologies
2.2.2 Rising Prevalence of Chronic Diseases
2.2.3 Growing Demand for Preventive Care
2.2.4 Shifting the Significance in Medicine, from Reaction to Prevention
2.2.5 Reducing Adverse Drug Reactions Through Pharmacogenomics Test
2.2.6 Potential to Reduce the Overall Healthcare Cost Across the Globe
2.3 Market Restraints
2.3.1 Unified Framework for Data Integration
2.3.2 Limited Knowledge About Precision Medicine Application
2.3.3 Lack of Robust Reimbursement Landscape
2.3.4 Regulatory Hurdles
2.4 Market Opportunities
2.4.1 Targeted Gene Therapy
2.4.2 Expansion into the Emerging Markets
2.4.3 Collaboration and Partnerships Across Value Chain Would Accelerate the Market Entry

3 Competitive Insights
3.1 Key Developments and Strategies
3.1.1 Joint Ventures, Partnerships, Agreements, and Collaborations
3.1.2 Product launches, Enhancements, and Upgradation
3.1.3 Product Approvals
3.1.4 Merger and Acquisitions
3.1.5 Business Expansion
3.1.6 Other Developments
3.2 Market Share Analysis
3.2.1 Market Share Analysis by Applied Sciences, 2017
3.2.2 Market Share Analysis by Precision Diagnostics, 2017
3.2.3 Market Share Analysis by Precision Therapeutics, 2017
3.2.4 Market Share Analysis by Digital Health and IT, 2017
3.3 Industry Attractiveness
3.3.1 Definition of Suppliers and Buyers in the Precision Medicine Market
3.3.2 Bargaining Power of Suppliers
3.3.3 Bargaining Power of Buyers
3.3.4 Threat of New Entrants
3.3.5 Threat of Substitute Products
3.3.6 Intensity of Competitive Rivalry
3.4 Supply Chain Analysis

4 Industry Insights
4.1 Patent Analysis
4.2 Legal Requirements and Regulations
4.3 Pipeline Analysis

5 Global Precision Medicine Market (by Ecosystem)
5.1 Overview
5.2 Applied Sciences
5.2.1 Genomics
5.2.1.1 Polymerase Chain Reaction (PCR)
5.2.1.2 Precision Medicine Next-Generation Sequencing (PM NGS)
5.2.1.3 Genome Editing
5.2.1.4 Other Technologies
5.2.2 Pharmacogenomics
5.2.3 Other Applied Sciences
5.3 Precision Diagnostics
5.3.1 Molecular Diagnostics (MDx)
5.3.1.1 Non-invasive Prenatal Testing (NIPT)
5.3.1.2 Companion Diagnostics
5.3.1.3 Liquid Biopsy
5.3.1.4 Other Molecular Diagnostics
5.3.2 Medical Imaging
5.3.2.1 Imaging Analytics
5.3.2.2 Imaging Computer-Aided Detection (CADx)
5.4 Digital Health and Information Technology
5.4.1 Clinical Decision Support Systems (CDSS)
5.4.2 Big Data Analytics
5.4.3 IT Infrastructure
5.4.4 Genomics Informatics
5.4.5 In-Silico Informatics
5.4.6 Mobile Health
5.5 Precision Therapeutics
5.5.1 Clinical Trials
5.5.2 Cell Therapy
5.5.3 Drug Discovery and Research
5.5.4 Gene Therapy

6 Global Precision Medicine Market (by Application)
6.1 Overview
6.2 Oncology
6.2.1 Government Initiatives
6.2.2 Key Insights
6.2.3 Drivers and Challenges
6.2.4 Cancer Precision Medicine Drugs and Indications
6.2.5 Recent Key Developments
6.3 Infectious Diseases
6.3.1 Infectious Diseases Precision Medicine Drugs and Indications
6.4 Neurology/Physiatry
6.4.1 Neurology Precision Medicine Drugs and Indications
6.5 Cardiovascular
6.5.1 Cardiovascular Precision Medicine Drugs/Tests/ and Indications
6.6 Lifestyle and Endocrinology
6.6.1 Endocrinology Precision Medicine Drugs and Indications
6.7 Gastroenterology
6.7.1 Gastroenterology Precision Medicine Drugs and Indications
6.8 Other Applications
6.8.1 Precision Drugs for Other Applications

7 Global Precision Medicine Market (by Region)

8 Company Profiles

  • Abbott Laboratories
  • Almac Group Ltd.
  • Amgen Inc.
  • ANGLE plc
  • Astellas Pharma Inc.
  • Astra Zeneca PLC
  • ASURAGEN INC.
  • Bio-Rad Laboratories, Inc.
  • bioMrieux SA.
  • Bristol-Myers Squibb Company
  • Canon Inc.
  • CETICS Healthcare Technologies GmbH
  • Danaher Corporation
  • Eli Lilly and Company Limited
  • Epic Sciences, Inc.
  • F. Hoffmann-La Roche AG
  • GE Corporation
  • Gilead Sciences, Inc.
  • GlaxoSmithKline Plc
  • IBM Corporation
  • Illumina, Inc.
  • Intomics A/S
  • Johnson & Johnson
  • Konica Minolta, Inc.
  • Laboratory Corporation of America
  • MDxHealth, Inc.
  • Menarini Silicon Biosystems, Inc.
  • Merck & Co., Inc.
  • Myriad Genetics, Inc.
  • Novartis AG
  • Oracle Corporation
  • Pacific Biosciences of California, Inc.
  • Partek, Inc.
  • Pfizer, Inc.
  • QIAGEN N.V
  • Quest Diagnostics Inc.
  • Randox Laboratories Ltd.
  • Sanofi SA
  • Sysmex Corporation
  • Teva Pharmaceuticals Industries Ltd.
  • Thermo Fisher Scientific, Inc.
  • TrovaGene, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/flnl3b/global_precision?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: 
CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics

Ads